Canada’s National Guideline for the Clinical Management of Opioid Use Disorder (OUD) has been updated to reflect the latest literature. The new document recommends buprenorphine and methadone as first-line treatments for OUD.

Yakovenko I., Mukaneza Y., Germe K., et al; on behalf of the Canadian Research Initiative in Substance Matters guideline development team

CMAJ, Nov 12, 2024 (EN)

TB epidemic is still a global problem: the World Health Organization (WHO) has released the Global tuberculosis report 2024 based on 2023 data.

World Health Organization, 2024 (EN)

ЦГЗ МОЗ України, 2024 (UA)

A new article in the Harm Reduction Journal, co-authored by UIPHP researchers, highlights the sustainability of opioid agonist therapy (OAT) programmes in the context of the transition from donor support to national funding in 4 countries of the EECA region: Belarus, the Republic of Moldova, Tajikistan, and Ukraine.

Stuikyte R., Varentsov I., Malikov N., Dvoriak S., Filippovych M., Latypov A., Kralko A., Latco A., Cook C.

Harm Reduction Journal, 2024 Oct (EN)

Карачевський А., Климчук В., Горбунова В.

ЦГЗ МОЗ України, 2024 (UA)

Machavariani E., Dumchev K., Pykalo I., Filippovych M., Ivasiy R., Esserman D., Madden L., Bromberg D., Haddad M., Morozova O., Bachar Ahmad B., Gómez D., Farnum S., Dvoriak S., Altice F.

Contemporary Clinical Trials, 2024 Nov (EN)

The World Health Organization has released updated guidelines on TB preventive treatment.